H.I.G. Capital Completes the Sale of BIOVECTRA
Headquartered in
H.I.G. acquired BIOVECTRA in November 2019 and successfully established the Company as an independent, standalone organization. H.I.G. supported the Company in strengthening the executive management team, successfully completing three major facility build-outs, and growing the sales pipeline significantly while shifting the Company’s business profile to focus more on commercial products. Due to these strategic initiatives, the Company achieved an industry-leading growth profile, resulting in an outstanding outcome for shareholders.
Oliver Technow, BIOVECTRA’s CEO, commented, “Today is a testament to the reputation BIOVECTRA has built as a trusted partner with our marquis roster of clients and to our efforts to continuously grow our service offering, ultimately better serving patients’ lives. We are grateful for H.I.G.'s role in our success these past five years and are excited to further build on this success with Agilent through this synergistic pairing.”
Mike Gallagher, Managing Director at H.I.G., commented, “The BIOVECTRA team has consistently done an exceptional job at executing value-added strategic initiatives, and we have been pleased to support them throughout our partnership to become a leader in the pharma CDMO space. We believe Agilent is a first-class organization that will help BIOVECTRA grow to even greater heights.”
Scott Zhu, Managing Director at H.I.G., added, “It has been a privilege to collaborate with Oliver and the entire BIOVECTRA team. Their hard work and commitment have driven exceptional growth, and we are proud to have helped them enhance their capabilities during this pivotal phase. We look forward to following the team’s continued success.”
Moelis & Company LLC, Morgan Stanley & Co. LLC, and RBC Capital Markets, LLC, were financial advisors to H.I.G.
About BIOVECTRA
Headquartered in
About H.I.G. Capital
H.I.G. is a leading global alternative investment firm with
- H.I.G.’s equity funds invest in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
- H.I.G.’s debt funds invest in senior, unitranche, and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. also manages a publicly traded BDC, WhiteHorse Finance.
- H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
- H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.
Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm’s current portfolio includes more than 100 companies with combined sales in excess of
*Based on total capital raised by H.I.G. Capital and affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240923272694/en/
Mike Gallagher
Managing Director
mgallagher@hig.com
Scott Zhu
Managing Director
szhu@hig.com
Alex Zisson
Managing Director
azisson@hig.com
1450 Brickell Avenue
31st Floor
P 305.379.2322
hig.com
Source: H.I.G. Capital